SEC Filing Summary for Biomea Fusion, Inc. - Form 4 Filing

This Form 4 filing details a stock option grant to Michael J.M. Hitchcock, Interim CEO and Director of Biomea Fusion, Inc. The option, exercisable for 667,477 shares of Common Stock, was granted on April 1, 2026, with a price of $0.0 per share. The option vests in 16 equal quarterly installments starting April 1, 2026, and will be fully vested by April 1, 2030, contingent upon continued service. The option has an exercise price of $1.49 and an expiration date of March 31, 2036. This transaction is classified as an acquisition of a derivative security.